{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:57Z","timestamp":1791925737912,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bioorg.2023.106659","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T15:16:17Z","timestamp":1686150977000},"page":"106659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex"],"prefix":"10.1016","volume":"138","author":[{"given":"Robert","family":"Murnane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mire","family":"Zloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Santana-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-2910","authenticated-orcid":false,"given":"Federico","family":"Brucoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106659_b0005","year":"2020"},{"key":"10.1016\/j.bioorg.2023.106659_b0010","article-title":"The WHO Global Tuberculosis 2021 Report\u2013not so good news and turning the tide back to End TB","author":"Jeremiah","year":"2022","journal-title":"Int. J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106659_b0015","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/acs.jmedchem.6b01718","article-title":"Rational design, synthesis, and biological evaluation of heterocyclic quinolones targeting the respiratory chain of Mycobacterium tuberculosis","volume":"60","author":"Hong","year":"2017","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106659_b0020","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"issue":"11-12","key":"10.1016\/j.bioorg.2023.106659_b0025","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bbabio.2012.11.008","article-title":"Structural analysis of cytochrome bc1 complexes: Implications to the mechanism of function","volume":"1827","author":"Xia","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106659_b0030.1","doi-asserted-by":"crossref","unstructured":"Husz\u00e1r S, Chibale K, Singh V. The quest for the holy grail: new antitubercular chemical entities, targets and strategies. Drug Discovery Today. 2020, 25(4), 772-80","DOI":"10.1016\/j.drudis.2020.02.003"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106659_b0030.2","doi-asserted-by":"crossref","unstructured":"Bahuguna A, Rawat S, Rawat DS. QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents. Medicinal Research Reviews. 2021, 41(4), 2565-2581.","DOI":"10.1002\/med.21779"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106659_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/acsmedchemlett.5b00324","article-title":"2-(Quinolin-4-yloxy) acetamides are active against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains","volume":"7","author":"Pissinate","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106659_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112179","article-title":"Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy) acetamide-based antituberculosis agents","volume":"192","author":"Borsoi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2023.106659_b0045","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acs.jmedchem.6b00245","article-title":"Searching for new leads for tuberculosis: design, synthesis, and biological evaluation of novel 2-quinolin-4-yloxyacetamides","volume":"59","author":"Pitta","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106659_b0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis","volume":"8","author":"Ballell","year":"2013","journal-title":"ChemMedChem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106659_b0055","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1039\/C6MD00236F","article-title":"SAR and identification of 2-(quinolin-4-yloxy) acetamides as Mycobacterium tuberculosis cytochrome bc 1 inhibitors","volume":"7","author":"Phummarin","year":"2016","journal-title":"MedChemComm"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106659_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2017.08.023","article-title":"Activity of 2-(quinolin-4-yloxy) acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing","volume":"51","author":"Subtil","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106659_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"Rybniker","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106659_b0070","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/AAC.03486-14","article-title":"Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis","volume":"58","author":"Arora","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106659_b0075","doi-asserted-by":"crossref","first-page":"e52951","DOI":"10.1371\/journal.pone.0052951","article-title":"Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB","volume":"7","author":"Abrahams","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2023.106659_b0080","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMc1913327","article-title":"Telacebec (Q203), a new antituberculosis agent","volume":"382","author":"de Jager","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2023.106659_b0085","doi-asserted-by":"crossref","first-page":"e69418","DOI":"10.7554\/eLife.69418","article-title":"Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates","volume":"10","author":"Zhou","year":"2021","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106659_b0090","doi-asserted-by":"crossref","first-page":"e02439","DOI":"10.1128\/AAC.02439-17","article-title":"Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels","volume":"62","author":"O'Malley","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.bioorg.2023.106659_b0095","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1021\/acs.jmedchem.8b00172","article-title":"Identification of morpholino thiophenes as novel Mycobacterium tuberculosis inhibitors, targeting QcrB","volume":"61","author":"Cleghorn","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106659_b0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acsinfecdis.7b00112","article-title":"Improved phenoxyalkylbenzimidazoles with activity against Mycobacterium tuberculosis appear to target QcrB","volume":"3","author":"Chandrasekera","year":"2017","journal-title":"ACS Infect. Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106659_b0105","doi-asserted-by":"crossref","first-page":"e02041","DOI":"10.1128\/aac.02041-21","article-title":"Triazolopyrimidines target aerobic respiration in Mycobacterium tuberculosis","volume":"66","author":"Shelton","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2023.106659_b0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbiomolbio.2020.02.001","article-title":"Targeting the cytochrome oxidases for drug development in mycobacteria","volume":"152","author":"Lee","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106659_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00232-017-9997-3","article-title":"Mycobacterial membrane proteins QcrB and AtpE: roles in energetics, antibiotic targets, and associated mechanisms of resistance","volume":"251","author":"Bown","year":"2018","journal-title":"J. Membr. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106659_b0120","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cmdc.201100309","article-title":"4-Substituted thioquinolines and thiazoloquinolines: potent, selective, and tween-80 in vitro dependent families of antitubercular agents with moderate in vivo activity","volume":"6","author":"Escribano","year":"2011","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106659_b0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein\u2212 ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:55:38Z","timestamp":1758617738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823003206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"alternative-id":["S0045206823003206"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106659","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106659"}}